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Mini abstract: A review of 935 consequtive laparoscopic choledochoscopies adressing the 
indications and techniques and evaluating the benefits of choledochoscopy as compared to 
blind basket bile duct explorations. The value of the Wiper Blade Manoeuvre for transcystic 
intrahepatic choledochoscopy as a tool to reduce the reliance on choledochotomy is 
examined.  
Abstract  
 Objective: This study aims to examine the indications, techniques and outcomes of 
choledochoscopy during laparoscopic bile duct exploration and evaluate the results of the 
Wiper Blade Manoeuvre (WBM) for transcystic intrahepatic choledochoscopy.  
Summary Background Data: Choledochoscopy has traditionally been integral to bile duct 
explorations. However, laparoscopic era studies have reported wide variations in 
choledochoscopy availability and use, particulary with the increasing role of transcystic 
exploration. 
Methods: The indications, techniques and operative and postoperative data on 
choledeochoscopy collected prospectively during 1320 transcystic and choledochotomy 
explorations were analysed.The success rates of the WBM were evaluated for the 3mm and 
5mm choledochocoscopes.  
Results: Of 935 choledochoscopies, 4 were performed during laparoscopic 
cholecystectomies and 931 during bile duct explorations (70.5%); 486 transcystic 
choledochoscopies (52%) and 445 through choledochotomies (48%). Transcystic 
choledochoscopy was utilised more often than blind exploration (55.7%% vs 44.3%) in 
patients with emergency admissions, jaundice, dilated bile ducts on preoperative imaging, 
wide cystic ducts and large, numerous or impacted bile duct stones. Intrahepatic 
choledochoscopy was successful in 70% using the 3mm scope and 81% with the 5mm scope. 
Choledochoscopy was necessary in all 124 explorations for impacted stones. 20 retained 
stones (2.1%) were encountered but no choledochoscopy related complications.  
Conclusions: Choledochoscopy should always be performed during a choledochotomy, 
particularly with multiple and intrahepatic stones, reducing the incidence of retained stones. 
Transcystic choledochoscopy was utilised in over 50% of explorations, increasing their rate 
of success. When attempted, the transcystic Wiper Blade Manoeuvre achieves intrahepatic 
access in 70-80%. It should be part of the training curriculum.  
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Laparoscopic common bile duct exploration (LCBDE) is increasingly recognised as the 
preferred method of bile duct clearance during laparoscopic cholecystectomy (LC) where the 
expertise and equipment exist (1,2).  While training courses and programmes enable more 
surgeons to perform bile duct explorations, the availability of facilities for intraoperative 
cholangiography (IOC) and specialised instruments, such as the choledochoscope, remain an 
obstacle in many units. Many studies suggest that blind basket trawling can achieve duct 
clearance in a significant percentage of patients. We demonstrated that 31% of patients with 
abnormal IOC had transcystic clearance of stones using blind basket trawling or their 
cholangiographic abnormalities resolved using glucagon administration and duct flushing (3). 
Some studies reported exceptionally high success rates using this approach. Czerwonko et 
al.(4) attempted 500 transcystic explorations (TCEs), completing 469 (93.8%) without 
choledochoscopy. 
The primary aim of this study was to analyse the indications, frequency and success rates of 
choledochoscopy in a large single surgeon series of LCBDEs. The secondary aims were to 
evaluate criteria suggestive of successfully using choledochoscopic TCE over blind basket 
trawling, to compare TCE choledochoscopy and CBDE choledochoscopy, to evaluate our 
Wiper Blade Manoeuvre for transcystic intrahepatic choledochoscopy and to describe 
techniques for optimising stone extraction and avoiding stone impaction, retained stones and 
damage to the instrument.  
Methods & Materials 
We reviewed prospectively collected data from 1320 bile duct explorations performed by a 
single surgeon (AHMN) over 28 years. The transition from open to LC  preserved the 
traditional single session management of all fit patients with Common bile duct stones 
(CBDS); performing routine IOC and when necessary LCBDE. The surgeon had already 
aquired wide choledochoscopy experience during open ductal explorations. The biliary 
service received most biliary emergencies including all patients with suspected CBDS from 
all departments, and 17% were transferred from or performed at other hospitals(5). Patient 
demographics, type of admission, clinical presentation, preoperative investigations, operative 
details, postoperative complications and follow-up were stored on a Microsoft Access 
database. Data analysis was conducted with emphasis on those utilising choledochoscopy.  
Informed consent was obtained from all patients, emphasising the specialization of the unit in 
single session management of CBDS. IRB approval was not required as the management 
protocols were consistent with the recommendations of national and international societies.  
Techniques 
All patients undergoing elective or urgent  LC had a four-port approach in the American 
position with one infraumbilical 10-12mm port inserted by modified open access and three 5-
 
mm ports; midline  epigastric, right subcostal in the midclavicular line and right flank in the 
anterior axillary line.  The subcostal port is inserted in line with the longtudinal axis of the 
cystic duct (CD) to facilitate inserting the cholangiography catheter and, if necessary, the  
choledochoscope. We have previously described our cholangiography technique (6).  Once 
stones were confirmed the surgeon proceeded to LCBDE, initially utilising the transcystic 
approach unless the number or size of stones, CD diameter or its anatomy indicated a 
choledochotomy.  
TCE was initially performed using blind basket trawling. The senior author later introduced 
the ‘basket in catheter’ technique (7) (Supplemental Media 1, 
http://links.lww.com/SLA/D100). Failure to retrieve stones after three attempts indicated 
choledochoscopy.  IOC may indicate mandatory choledochoscopy where blind exploration 
could result in intramural CD stone impaction (Supplemental data file 1, 
http://links.lww.com/SLA/D94). A choledochoscope (most TCEs are carried out using a 3 
mm Choledocho-Fiberscope, Karl Storz, Tutlingen, Germany) is inserted within an 
Applicator and Guide Tube (Karl Storz, Tutlingen, Germany) via the right subcostal port. 
The guide reduces scope looping, helps to direct and stabilise it and prevents its damage. A 
5mm scope is inserted directly through the disposable 5mm port.  
Choledochoscope orientation and movements are checked after introduction prior to 
manipulation into the CD/CBD without trying to push it using graspers as this may crush the 
instrument. The scope should be kept straight as bending it at weak points causes damage or 
obstruction to the advancement of baskets. It should not be flexed onto the tip of its 
introducer or the access cannula and should be withdrawn completely into its introducer 
under vision before removal. Care must be taken during handling, placement onto instrument 
trays and during storing or sterilising the scopes. 
The tip of the scope is inserted into the CD opening, initially pushing against the posterior 
wall before flexing it anteriorly to lift the CD anterior wall and advancing it in small “snake-
like” movements of the tip of the scope with low irrigation until it enters the CBD. 
(Supplemental Media 2, http://links.lww.com/SLA/D101). It is advantageous to advance the 
5mm port cannula towards the cystic duct, reducing scope looping and facilitating its 
progress into the CBD. Advancing the choledochoscope through the CD may occasioanlly 
need to be done under vision to negotiate CD valves and reach the CD/CBD junction  
Once in the CBD it’s important to maintain low irrigation to prevent proximal stone 
migration.  A suitable basket is introduced through the scope channel and stones are engaged.   
The choledochoscope is then withdrawn keeping the stone under vision a short distance from 
the tip. This keeps the CBD lumen in view to avoid missing other stones and avoids scope 
damage. The process is repeated until the CBD is clear.  Large, difficult to deliver, stones can 
be pulled into the CD stump, crushed with curved dissectors and retrieved in fragments. 
Alternatively a longitudinal incision is made on the CD towards the CBD, not reaching the 
junction, to help stone extraction.  Stones that are too hard to crush or too large to deliver are 
pushed back into the CBD and other measures are used for fragmentation e.g laser lithotripsy. 
 
A 5-mm choledochoscope is used if the CD was wide enough. When difficulty is encountered 
a 5Fr cholangiography catheter may be inserted into the choledochoscope channel, passed 
under vision into the intramural CD and used as a guide over which the choledochoscope is 
advanced.  
“Intrahepatic choledochoscopy may be necessary to confirm clearance or to capture stones 
that are not floating or are too numerous to manipulate into the distal CBD. The WBM (8) is 
attempted to deflect the choledochscope into the proximal ducts and requires favorable 
anatomy of the CD/CBD junction as well as moderate dilatation of the CBD, easily assessed 
on the IOC. With the choledochoscope visualising the lower CBD it is withdrawn gradually 
and, at the same time, the tip is deflected towards the anterior wall. The scope is rotated anti-
clockwise until the light at its tip is visible through the anterior CBD wall. The head of the 
scope is then rotated 180 degrees in the same direction while firmly holding the lever in 
position, mainatining the tip in flextion. The tip of the introducer is then moved below the 
CD opening directing the scope towards the common hepatic duct and, at the same time, 
straightening the tip and advancing the scope into the duct. A slight anti-clockwise rotation 
will usually allow the scope into the right hepatic duct. The right duct system is inspcted, 
advancing then withdrawing the scope from smaller ducts. The scope is again withdrawn to 
the confluence of the right and left hepatic ducts (which can be confirmed on seeing the light 
at the tip on the laparoscopic view or visualising the lumen of the left hepatic duct). A slight 
clockwise rotation will allow the scope to advance into the left duct system with selective 
duct by duct inspection facilitated by subtle inward/outward movements as well as tip 
deflection (Supplemental Media 3, http://links.lww.com/SLA/D102). The WBM can 
occasionally be performed using the choledochscopic view, subject to favorable anatomy. 
The scope is withdrawn until the junction of the CD/CBD is visible. The same moves are 
then performed to deflect the tip of the scope into the common hepatic duct. A reverse WBM 
is used on rare occasions when the default direction of the scope upon entering the CD is 
towards the intrahepatic ducts.” 
Choledochoscopy confirms clearance, visualises difficult large or impacted stones and helps 
to retrieve intrahepatic stones, It is also essential if transcystic removal of stents is required, 
saving occasional choledochotomies (as stents can prevent stone extraction via TCE) or later 
endoscopic removal. (Supplemental data file 2, http://links.lww.com/SLA/D95) 
Before concluding CBD inspection a half open basket is psssed through the ampulla under 
vision to exclude impacted ampullary stones. Choledochoscope passage into the duodenum 
is occasionally possible and may be used to transfer engaged stones to the duodenum rather 
than attempting transcystic extraction (Supplemental Media 4, 
http://links.lww.com/SLA/D103). This is particulary useful in patients who had a previous 
sphincterotomy and it avoids negotiating stone removal from the CD. 
Following choledochotomy exploration the 5mm choledochoscope is used to inspect the 
opening of the intramural CD into the CBD while passing a cholangiography catheter, a 
basket or a 3mm choledochoscope (Figure 1) transcystically through the subcostal port. This 
 
will occasioanlly extract CD stump or intramural stones that may have migrated during the 
exploration (Supplemental Media 5, http://links.lww.com/SLA/D104). This may also be done 
by passing the scope retrogradely from the CBD into the CD (subject to favourable 
anatomical configuration) to inspect the CD lumen,  allowing the irrigation fluid, a catheter 
or a basket to emerge from its opening under laparoscopic vision, confirming clearance. 
(Supplemental Media 6, http://links.lww.com/SLA/D105).   
A final passage of the choledochoscope is recommended should completion cholangiography 
be equivocal.  
Should the surgeon choose to place a transcystic biliary drain the choledochoscope is used to 
check the position of the tip of the tube, ensuring it remains above the ampulla rather than 
pass into the duodenum. While transcystic biliary drainage is our preferred method we have 
used T-tubes, primary closure and internal stenting, subject to case by case selection. The 
vertical choledochotomy is closed using interrupted 3/0 Vicryl on ski needles. Should a T-
tube be used the sutures are placed above it. A subhepatic drain will always be inserted when 
a choledochotomy has been performed.  
Statistical analysis 
Qualitative data were given as frequency and percentages.  Pearson uncorrected Chi-Square 
test was calculated in Statpages to calculate p value and odds ratio with 95% confidence 
interval.  P value of < 0.05 was considered to be statistically significant. 
Results 
1320 LCBDEs were performed between 1992 and 2020 ; 872 (66 %) transcystic explorations 
(TCE), and 448 (34%) via choledochotomy. 
Of 935 choledochoscopies performed over this period, 931 (70.5%) were done during bile 
duct explorations including 486 TCE and 445 choledochotomies.  4 choledochoscopies were 
performed during LCs but not recorded as ductal exploration as they had no bile duct stones. 
Two had impacted CD stones, one a CD/CBD junction stricture and one a failed IOC.  
64 % were female, the mean age was 63 years (range 8-91) and 80 % were emergency 
admissions.  The admission diagnosis was obstructive jaundice with or without cholangitis in 
565 patients (60.6%), acute biliary pain in 136 (14.5%), pancreatitis in 94 (10%) and acute 
cholecystitis in 51 (5.4 %). Ultrasound scanning showed multiple gallbladder stones in 788 
(84%) and dilated bile ducts in 563 (60%). Preoperative MRCP was done in 189 patients 
(20.2%) and ERCP in 96 (10.2%). 833 patients (89%) were therefore suspected of having 
CBDS.  
Transcystic choledochoscopy vs blind basket exploration: 
Transcystic exploration was carried out in 872 patients, choledochoscopy being used in 486 
(55.7%). These were more likely to be emergency admissions with obstructive jaundice or 
 
acute biliary pain whose ultrasound scans (and, if carried out, MRCP) showed dilated bile 
ducts. There were significantly more patients with risk factors for CBDS in this group than in 
patients whose explorations were performed using the basket alone technique. Blind basket 
explorations (44.3%) were more common in females, elective admissions or with chronic 
biliary colic. (Table 1). 
A comparison between the operative data and postoperative outcomes in choledochoscopic 
vs. blind TCE is shown in Table 2. The operative difficulty grade, a wide cystic duct, and the 
need for biliary drainage were all significantly higher in patients requiring choledochoscopy. 
All impacted stones occurred in the choledochoscopy group reflecting the fact that 
disimpaction or fragmentation always needed to be carried out under vision. 
When transcystic choledochoscopy was performed the 3 mm choledochoscope was used in 
381 patients (78.4%) and the 5 mm scope in 105 (21.6%). However, the 5-mm scope was 
preferred if the cystic duct was wide enough.  Only distal choledochoscopy was necessary in 
201 patients with few lower CBD stones, completion cholangiography showing no indication 
for intrahepatic inspection. Intrahepatic choledochoscopy using the WBM was attempted in 
285/486 (58.6%) of TCEs and was successful in 207 (72.6%). When attempted with the 5mm 
scope the WBM was achieved in a higher percentage (52/64, 81%) than with the 3mm scope 
(155/221, 70%) (Table 3).  
Transcystic choledochoscopy versus transcholedochal choledochoscopy: 
A 5mm choledochoscope was used in 445 transcholedochal explorations. The median age, 
sex and type of admission of those patients were the same as those undergoing transcystic 
choledochoscopy. The clinical presentations, radiological investigations and CBD stone risk 
are shown in Table 4. Choledochoscopy facilitated the extraction of stones and the insertion 
of transcystic biliary drains in 167 patients and stents on 16 occasions where internal 
drainage was indicated. The removal of stents that may have been left during a preoperative 
ERCP usually required a choledochotomy. However, in this series transcystic removal of 
biliary stents was achieved in 6 cases under choledochoscopic control, visualising the upper 
end of the stent and engaging it with a basket. 
The operative and postoperative characteristics of transcystic and transcholedochal 
choledochoscopy showed significantly more LC difficulty grades IV, cystic duct stones, 
impacted CBD stones and biliary drains in the choledochotomy group. As would be expected 
the utilisation of biliary drains, open conversions, morbidity, and reoperations were also 
significantly higher (Table 5). However, such parameters were unrelated to the use of 
choledochoscopy. 
Choledochoscopy was necessary during 51 of 58 explorations for Mirizzi syndrome; 31 
choledochotomies and 20 TCE(9). It was also used in all 124 patients with impacted stones; 
81 during choledochotomy and 43 during TCE. It facilitated access, dislodgement under 
 
vision and fragmentation using biopsy forceps or laser lithotripsy and only three patients in 
this group had retained stones.  
Retained stones occurred in 20 patients (2.1%) who had a choledochoscopic exploration; 15 
through choledochotomy and 5 a TCE.  
No operative or postoperative complications, open conversions, readmissions or 
reinterventions resulted from the use of the choledochoscope. 
 
Discussion 
Blind basket exploration was achieved in 44.3% of 872 TCEs in this study. However, large, 
multiple or impacted stones rendered blind exploration either time consuming or impossible 
and subsequently the choledochoscope was used during most TCEs. Case selection for 
choledochoscopy was determined by a number of factors including the presence of numerous 
stones, intrahepatic stones and the need to confirm complete clearance of the bile ducts when 
post-exploration completion cholangiography remained equivocal.  
Capagnacci et al. (10) compared the blind basket technique with choledochoscopy in a 
randomised trial.  Although blind basket exploration achieved stone clearance in 77.5%, 
choledochoscopy was better in terms of higher stone removal rate and fewer minor 
complications despite a longer operation time.  
Topal et al (11) examined 113 LCBDEs in a prospective study comparing fluoroscopically 
guided stone removal with  choledochoscopic TCE. Choledochoscopy exploration had a 
shorter operating time but stone clearance and morbidity rates were similar. Their basket 
technique was used early in their experience and the longer time was probably a reflection of 
the learning curve rather than evidence that choledochoscopic exploration is faster. As we do 
not dilate the CD our exploration time is determined by many factors including whether 
negotiating the CD is difficult, stone fragmentation is necessary or the WBM is attempted.  
Our own experience is that the TCE operative time is less important than selecting the 
appropriate technique for the patient. There was no statistical difference in the surgery time 
between blind basket and choledochoscopsy TCE.(Table 2) 
TCE Choledochoscopy technique  
The introduction of even the narrow 3mm scope into the CD may be difficult due to a small 
duct calibre or the presence of valves. Several authors reported techniques for dilating the CD 
either with forceps (12,13), balloon dilators (14, 15) or blunt flexible dilators (16) to facilitate 
choledochoscope insertion .  However, CD dilatation is not without problems. Zhang et al 
(16) reported a ruptured CD resulting in open conversion. Carroll et al (15) and Al-Habbal 
(17) also reported CD laceration or avulsion resulting in failure. Railroading the scope over a 
floppy tipped guidewire has also been reported (17,18). Navaratne et al (18) used trans-
infundibular choledochoscopy when inflammation at the cystic pedicle makes it difficult or 
impossible to access the CD for dilatation. All the above authors described CD dissection 
towards the lateral wall of the CBD in order to display a right angled junction. However, 
there was no mention of CD/CBD configurations, such as a CD entering the medial side of 
the CBD rendering that dissection impossible or undesirable.  
The group of Martinez-Isla, Al-Musawi and Navaratne (18,19,20) described complete 
separation of the gallbladder from the liver, leaving it attached to the CBD only through the 
CD. They maintained that this achieves a right angled CD/CBD junction facilitating 
choledochoscope insertion and proximal access using our WBM. 
 
In our practice we have not adopted CD dilatation as some configurations of the CD/CBD 
junction make it impossible to dilate the full length of the duct. Moreover, dilating the 
intramural part of the CD may be undesirable due to the risk of CBD disruption.  When 
valves or a narrow calibre preclude scope passage our first approach is to perform further 
dissection and incise the CD closer to the CBD. This allows the 3mm scope to pass into most 
CDs. As a medial low CD entry will make the WBM impossible choledochoscopy should be 
performed without prior attempts at blind trawling to avoid stones moving above the CD 
junction and a completion choiledochoscopy carried out and used to obtain cholangiography 
confirming intrahepatic clearance. (Supplemental data file 3, http://links.lww.com/SLA/D96)  
Achieving intra-hepatic access is a measure of success of choledochscopic TCE. In our 
practice it was only thought necessary and attempted in 59% of explorations, when initial or 
completion cholangiography showed intrahepatic stones. It may be clear from the IOC that 
the WBM would not be successful. A low or medial insertion of the CD would make it 
physically impossible to angle the the scope at multiple points to reflect it upwards and 
achieve intrahepatic access. Our preliminary report on the WBM (8) included 120 transcystic 
choledochoscopies in which transcystic intrahepatic access was successful in 49 (40.8%). The 
refinement of the technique and incraeasing experience have resulted in higher success rates. 
When indicated and attempted, the WBM was achieved in 81% using the 5mm scope and 
70% with the 3mm scope, a trend towards significance (p=0.79). Although the WBM was 
used in a number of studies (19,21,22) the numbers were small and neither the size of 
choledochoscope nor the success rates were reported. 
Choledochotomy 
If a choledochotomy is made a choledochoscope should always be used to visualise the CBD. 
Some stones may simply be squeezed out of the choledochotomy or removed using the 
conventional methods of irrigation, balloon trawling or basket retrieval. Others, partciularly 
intrahepatic and impacted stones, will require removal under vision. The exploration should 
always be concluded with a choledochoscopy. The 5mm scope is used, being easier to handle 
and less fragile than the 3mm scope. The epigastric port is used for scope insertion, giving a 
better angle of access to both intrahepatic and extrahepatic ducts. Right subcostal port 
insertion may be preferred for multiple or impacted intrahepatic stones as it allows scope 
stability while the surgeon attends to positioning, basket manipulation or laser use. The 
choledochoscopy mechanics remain as described.  
Choledochoscopy and Impacted stones 
It is seldom possible to resolve impacted stones without choledochoscopic control. All 
methods of disimpaction or fragmentation must be carried out under vision in order to 
achieve successful extraction while avoiding injury to the bile ducts. Impacted intrahepatic 
stones can be challenging and time consuming due to difficult choledochoscopic access and 
demanding fragmentation (Supplemental data file 4, http://links.lww.com/SLA/D97). Open 
conversion, therefore, will seldom make the procedure any easier and most such patients may 
 
have already had multiple failed ERCP attempts. Distal CBD stone impaction is more likely 
in jaundiced patients in whom the ultrasound scan detects CBD stones. Even small stones can 
be challenging to remove as they often impact in a pouch which is eccentric to the CBD 
making it impossible to open a basket around the stone. Fogarty balloons passed through the 
subcostal port may be used alongside retrieval baskets through the choledochoscope, 
attempting to evert such a pouch , dislodge a stone and engage it. This allows two 
instruments to be used simultaneously under vision within the bile duct (Supplemental Media 
7, http://links.lww.com/SLA/D106). Early in the series we used biopsy forceps or ultrasound 
lithotripsy but later used laser to fragment stones(Supplemental Media 8 A,B&C, 
http://links.lww.com/SLA/D107, http://links.lww.com/SLA/D108, 
http://links.lww.com/SLA/D109).  However, the consistency and the size of the stone can 
make this difficult and time consuming. Laser could be used to fragment and remove 
impacted intrahepatic stones which are almost impossible to disimpact and remove 
endoscopically or lower CBD stones which are a risk factor for ERCP complications. 
Navarro-Sanchez et al (23) reported the Laser Assisted Bile Duct Exploration by 
Laparosendoscopy (LABEL) technique of laser fragmentation in complicated TCE. In 
another publication from the same group (24) TCE was successful in two thirds of patients 
and 16.2% required LABEL to achieve transcystic extraction. 7/31(22.6%) of  TCEs failed 
despite the use of laser. However, the LABEL group had more bile leaks requiring 
reintervention, longer operative times and longer post-operative hospital stay. The group’s 
large percentage of explorations requiring laser is likely due to personal preference and 
experience as less than 1% of 1320 CBDEs in our series needed laser. Other large studies 
with high success rates of TCE also reported occasional laser use (4). It is our view, 
therefore, that routine use of laser can not be recommended on the basis of necessity or 
safety. 
The use of electro-hydraulic lithotripsy (EHL) to fragment impacted stones has also been 
reported (19).  
Special uses of choledochoscopy: 
Transcystic choledochoscopic retrieval of intrahepatic stones using the WBM has been used 
by the first author since 2002 and described in 2012(8).  Once achieved, intrahepatic 
choledochoscopy should progress from the main ducts to their tributaries in a systematic 
fashion to avoid missing stones.  It is often possible to identify the right hepatic duct and 
occasionally the left hepatic duct by observing the light at the tip of the choledochoscope 
through the duct wall on the laparoscopic view (Supplemental Media 9, 
http://links.lww.com/SLA/D110).  This technique will also occasionally identify extrahepatic 
right hepatic or sectoral ducts, clarifying duct anatomy, avoiding such ducts during difficult 
gallbladder separation and checking their intergrity afterwards. 
Choledochoscopic cholangiography: when insertion or the WBM are difficult to repeat it 
may be advantageous to confirm intrahepatic duct clearance before removing the 
choledochoscope. The C-Arm is positioned and contrast is injected through the 
 
choledochoscope channel obtaining a dynamic IOC (Figure 2). The viscosity of the contrast 
material may allow intrahepatic stones to move down to the CBD. Choledochoscopy could 
also be used as a alternative to IOC in pregnant patients to avoid using x-rays or when 
cholangiography is unavailable.   
Choledochoscopic suction: Recovery of intrahepatic stones or fragments into the CBD may 
be achieved using irrigation followed by suction to move the stones towards the 
choledochoscope to engage and remove them.  Some stones may be transferred to the 
duodenum or occasionally crushed and fragmented. Although the 3mm scope does not have a 
dedicated suction button or channel we have used a 3- way tap on the irrigation port to 
provide alternate irrigation and suction.  
We have also used the choledochoscope to locate and remove spllied stones. The flexible 
instrument can reach the space lateral to the liver or the subphrenic space more readily than 
the laparoscope and facilitates basket stone retrieval. (Supplemental Media 10, 
http://links.lww.com/SLA/D111) 
Choledochoscopy training 
Aquiring and refining choledochoscopy skills are essential componenets of mastering 
LCBDE. Teitlebaum et al (25) used a simulator allowing senior surgery residents to perform 
specific tasks before proceeding to simulated explorations. A two months curriculum of 
practicing procedural skills impoved residents performance to the level of mastery. Resident 
assessment scores on inserting and manipulating the choledochoscopes improved 
significantly and were reflected in increased confidence in performing both transcystic and 
transcholedochal choledochoscopy.  However, tissue dissection to simulate exposing and 
preparing the CBD was not possible on the synthetic model. Li et al (26) used a 3D printed 
biliary tract modle as a choledocghoscopy training tool. The anatomically realistic model 
improved trainees ability to manipulate the scope. However, it could not reporoduce tissue 
elasticity and the loss of normal texture affected tactile feedback.  
Drissen et al (27) designed a synthetic bile duct model which was assessed by experienced 
surgeons during a choledochoscop hands-on course (Supplemental data file 5, 
http://links.lww.com/SLA/D98). Although the model offered a realistic experience, the 
internal friction of the artificial CBD was high and the rating of the compliance, tactile 
characteristics and clour was lower than with animal tissue.  
Navarro-Sanchez et al (28) used a pocrine aorta model concluding that although live animal 
modles provided the most realistic experience they were expensive and raised ethical and 
regulatory issues.  However, their model could not reproduce realistic transcystic 
choledochoscopy, or simulate intrahepatic duct anatomy or the WBM.  
The first author conducted hands-on courses using cow liver models for over 20 years 
(Supplemental data file 6 A& B& C, http://links.lww.com/SLA/D99). These provide realistic 
 
anatomy and tissue texture.  Cholangiography, TCE, choledohotomy and choledochoscopy 
tasks are reproducible resulting in skills consolidation. Stones of various sizes can be inserted 
into the ducts to allow realstic stone retrieval practice. When cow livers were not available 
large sheep, goat or pig livers are used subject to local regulations. 
Component training: Our training protocol is based on consolidation of skills and the 
optimal use of choledochoscopy through hands-on LCBDE in one or 2-day courses. Clinical 
component training follows, progressing through IOC, TCE, and choledochotomy. Senior 
trainees are able to perform most LCBDE during their 6-month placements (29).  
Challenges of the use, maintenance and sterilisation of the choledochoscope:  
The sterilisation of choledochoscopes usually occurs offsite, with a  minimum 48 hour 
turnaround in the authors’ institutions.  Centres performing high volume LCBDEs require a 
number of scopes in circulation to ensure their continued availability. The Ambu® aScope 
(Ambu, Denmark) bronchoscope has been used as a cholecdoscope (30,31). Although it is 
not designed for fluid irrigation it is a useful alternative when the standard instruments are 
not available. Disposable uretroscopes can be used for inspection but they are too long to 
allow the use of most available retrieval baskets. 
Video choledochoscopes provide higher quality images than fibreoptic scopes and are easier 
to set up, having an integrated light source.  However, they are more expensive to repair.  
The SpyGlass Discover choledochoscope (Boston Scientific, Marlborough, Massachusetts, 
USA) at 3.6mm external diameter, is slightly larger than the fiberoptic scopes available. 
However, it has the advantage of 2 way tip defection and the ability to lock the scope’s 
position to facilitate stone capture. It also has separate irrigation and instrument channels, 
allowing good irrigation pressure when a basket is in use.  
Conclusion: 
Although blind basket trawling is successful in clearing between 30 and 80% of stones during 
TCE, choledochoscopy is an essential tool for any unit adopting single session laparoscopic 
treatment of CBDS. Transcystic choledochoscopy is necessary in over half of TCEs and, 
when indicated, the Wiper Blade Manoeuvre achieves intrahepatic choledochoscopy to 
confirm stone clearance in 70-80%. Choledochoscopy should be routine when a trans-
choledochotomy exploration is performed. It is essential for intrahepatic and impacted stone 
retrieval, reducing the incidence of failed LCBDE and retained stones. 
Disclosure: Ahmad H M Nassar has directed laparoscopic bile duct exploration 
/choledochoscopy hands-on courses supported by Karl Storz. There are no formal links or 
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Legends for figures: 
Figure 1:  The opening of the CD into the CBD is inspected with a 5mm choledochsocpe 
through the choledochotomy while a 3mm scope is passed into the CD to exclude intramural 
stones. 
 
Figure 2:  Choalngiography obtained through the choledochoscope channel to view 
intrahepatic ducts before concluding the WBM. 
 
 
Table 1: Preoperative characteristics associated with using choledochoscopy versus 
blind basket transcystic exploration. 
Characteristics Choledochoscopy 
(n = 486) 
Blind basket 
(n = 386) 
P value OR (95% CI) 
Median Age (range) 57 (8-89) years 55 (16-90) years < 0.001  
Female Sex 298 (61.3%) 283 (73.3%) < 0.001 0.577 (0.432, 0.771) 
Emergency admission 392 (80.7%) 243 (63.0%) < 0.001 2.454 (1.808, 3.331) 
Admission diagnosis     
Jaundice 259 (53.3%) 119 (30.8%) < 0.001 2.560 (1.935, 3.387) 
Acute Pain 302 (62.1%) 181 (46.9%) < 0.001 1.859 (1.417, 2.438) 
Chronic Biliary Pain 102 (21.0%) 138 (35.8%) < 0.001 0.477 (0.353, 0.645) 
Cholangitis 42 (8.6%) 10 (2.6%) < 0.001 3.557 (1.761, 7.185) 
Acute Pancreatitis 72 (14.8%) 48 (12.4%) 0.311 1.225 (0.827, 1.813) 
Acute Cholecystitis 35 (7.2%) 39 (10.1%) 0.127 0.690 (0.428, 1.113) 
Ultrasound scan     
Multiple stones 423 (87.0%) 367 (95.1%) < 0.001 0.348 (0.204, 0.592) 
Contracted/Thick GB 94 (19.3%) 62 (16.1%) 0.209 1.253 (0.881, 1.783) 
Dilated CBD 243 (50.0%) 94 (24.4%) < 0.001 3.106 (2.318, 4.162) 
MRCP 97 (20.0%) 28 (7.3%) < 0.001 3.188 (2.045, 4.972) 
CT Scan 57 (11.7%) 21 (5.4%) 0.001 2.309 (1.374, 3.882) 
ERCP 24 (4.9%) 9 (2.3%) 0.045 2.176 (0.999, 4.738) 
CBD Stone Risk  416 (85.6%) 242 (62.7%) < 0.001 3.536 (2.551, 4.902) 
Note: Data in parentheses are 95% confidence intervals. GB = Gallbladder, CBD = Common 
Bile Duct, MRCP = Magnetic resonance cholangiopancreatography, CT = Computerized 
tomography, ERCP = Endoscopic retrograde cholangiopancreatography. 
 
Table 2: Operative and postoperative data of transcystic exploration using 
choledochoscopy versus blind basket exploration. 
Characteristics Choledochoscopy (n 
= 486) 
Blind basket 
(n = 386) 
P value OR (95% CI) 
Difficulty Grading     
I 76 (15.6%) 96 (24.9%) 0.001 0.560 (0.400, 0.784) 
II 131 (27.0%) 127 (32.9%) 0.056 0.753 (0.562, 1.008) 
III 151 (31.1%) 97 (25.1%) 0.053 1.343 (0.995, 1.812) 
IV 104 (21.4%) 60 (15.5%) 0.028 1.479 (1.042, 2.100) 
V 24 (4.9%) 6 (1.6%) 0.006 3.290 (1.331, 8.131) 
Wide Cystic Duct 205 (42.2%) 88 (22.8%) < 0.001 2.450 (1.8181, 3.301) 
Cystic Duct Stones 155 (31.9%) 141 (36.5%) 0.151 0.814 (0.614, 1.078) 
Number of CBD stone 2 (1-50) 2 (1-30) < 0.001  
Size Of CBD stone 8 (2-22) mm 6 (3-15) mm < 0.001  
Impacted CBD stone 43 (8.8%) 0 < 0.001   
Use of Glucagon 248 (51.0%) 252 (65.3%) < 0.001 0.554 (0.421, 0.729) 
Operative Time (mins) 95 (42-285) 75 (40-265) 0.965 1.008 (0.719, 1.412) 
Transcystic biliary drain 91 (18.7%) 38 (9.8%) < 0.001 2.110 (1.407, 3.163) 
Open Conversions 1 (0.2%) 2 (0.5%) 0.434 0.396 (0.036, 4.382) 
Retained Stones 5 (1.0%) 6 (1.6%) 0.490 0.658 (0.199, 2.174) 
Complications 48 (9.9%) 40 (10.4%) 0.813 0.948 (0.609, 1.476) 
Reoperation 2 (0.4%) 1 (0.3%) 0.703 1.591 (0.144, 17.610) 
Readmissions 25 (5.1%) 23 (6.0%) 0.600 0.856 (0.478, 1.533) 
Number of Episodes 1 (1-5) 1 (1-4)  0.129  
Total Hospital Stay 6 (1-160) days 5 (1-49) days < 0.001  
Presentation to resolution 
interval 
1 (1-112) week 1 (1-72) week 0.515  
Note: Data in parentheses are 95% confidence intervals. CBD = Common Bile Duct. 
 
Table 3: Patients undergoing transcystic choledochoscopy.  Rates of attempted and 
successful Wiper Blade Maneuver using 3mm versus 5mm scopes. 
Choledochoscope 3mm scope 
(n = 381) 
5mm scope 
(n = 105) 
P value OR (95% CI) 
CBD only - 
Intrahepatic NOT 
indicated 
160 (42.0%) 41 (39.0%) 0.587 1.130 (0.727, 1.758) 
Intrahepatic 
attempted 
221 (58.0%) 64 (61.0%) 0.587 0.885 (0.569, 1.376) 
Intrahepatic 
successful WBM 
155 (70.1%) 52 (81.3%) 0.079 0.542 (0.272, 1.081) 
Note: Data in parentheses are 95% confidence intervals. CBD = common bile duct, WBM = 












P value OR (95% CI) 
Median Age (Range) 57 (8-89) years 73 (17-91) years < 0.001  
Female Sex 298 (61.3%) 297 (66.7%) 0.085 0.790 (0.604, 1.033) 
Emergency admission 392 (80.7%) 356 (80.0%) 0.801 1.043 (0.754, 1.441) 
Admission diagnosis     
Jaundice 259 (53.3%) 293 (65.8%) < 0.001 0.592 (0.454, 0.771) 
Acute Pain 302 (62.1%) 246 (55.3%) 0.034 1.328 (1.022, 1.725) 
Chronic Biliary Pain 102 (21.0%) 112 (25.2%) 0.130 0.790 (0.582, 1.072) 
Cholangitis 42 (8.6%) 60 (13.5%) 0.018 0.607 (0.400, 0.921) 
Acute Pancreatitis 72 (14.8%) 22 (4.9%) < 0.001 3.344 (2.036, 5.493) 
Acute Cholecystitis 35 (7.2%) 16 (3.6%) 0.016 2.081 (1.135, 3.815) 
     
 
Ultrasound scan     
Multiple stones 423 (87.0%) 361 (81.1%) 0.013 1.562 (1.095, 2.229) 
Contracted/Thick GB 94 (19.3%) 69 (15.5%) 0.124 1.307 (0.929, 1.838) 
Dilated CBD 243 (50.0%) 320 (71.9%) < 0.001 0.391 (0.297, 0.513) 
     
MRCP 97 (20.0%) 92 (20.7%) 0.786 0.957 (0.695, 1.317) 
CT Scan 57 (11.7%) 42 (9.4%) 0.258 1.275 (0.837, 1.943) 
ERCP 24 (4.9%) 73 (16.4%) < 0.001 0.265 (0.164, 0.428) 
     
CBD Stone Risk  416 (85.6%) 415 (93.3%) < 0.001 0.430 (0.274, 0.673) 
Note: Data in parentheses are 95% confidence intervals.  TC = Transcystic, CBDE = 
Common bile duct exploration, GB = Gallbladder, CBD = Common Bile Duct, MRCP = 
Magnetic resonance cholangiopancreatography, CT = Computerized tomography, ERCP = 
Endoscopic retrograde cholangiopancreatography. 
* 4 more transcystic choledochoscopies were not recorded as duct explorations. 
 




(n = 486*) 
Transcholedocal 
Choledochoscopy (n = 
445) 
P value OR (95% CI) 
Cholecystectomy Difficulty 
Grading 
    
I 76 (15.6%) 43 (9.7%) 0.006 1.733 (1.163, 2.581) 
II 131 (27.0%) 112 (25.2%) 0.535 1.097 (0.818, 1.471) 
III 151 (31.1%) 115 (25.8%) 0.078 1.293 (0.971, 1.722) 
IV 104 (21.4%) 148 (33.3%) < 0.001 0.546 (0.408, 0.732) 
V 24 (4.9%) 27 (6.1%) 0.449 0.804 (0.457, 1.416) 
     
Wide Cystic Duct 205 (42.2%) 175 (39.3%) 0.376 1.126 (0.866, 1.463) 
Cystic Duct Stones 155 (31.9%) 102 (22.9%) 0.002 1.575 (1.176, 2.109) 
Number of CBD stone 2 (1-50) 5 (1-100) < 0.001  
Size of largest CBD stone 8 (2-22) mm 15 (2-30) mm < 0.001  
Impacted CBD stone 43 (8.8%) 81 (18.2%) < 0.001 0.436 (0.294, 0.647) 
Use of Glucagon 248 (51.0%) 97 (21.8%) < 0.001 3.738 (2.806, 4.980) 
 
Operative Time (mins) 95 (42-285) 170 (55-630) < 0.001  
Transcystic biliary drain 91 (18.7%) 167 (37.5%) < 0.001 0.384 (0.285, 0.517) 
T-Tubes 5 (1.0%) 218 (49.0%) < 0.001 0.011 (0.004, 0.027) 
Open Conversions 1 (0.2%) 13 (2.9%) 0.001 0.069 (0.009, 0.526) 
Retained Stones 5 (1.0%) 15 (3.4%) 0.014 0.298 (0.107, 0.827) 
Complications 48 (9.9%) 106 (23.8%) < 0.001 0.350 (0.242, 0.507) 
Reoperation 2 (0.4%) 11 (2.5%) 0.007 0.163 (0.036, 0.740) 
Readmissions 25 (5.1%) 74 (16.6%) < 0.001 0.272 (0.169, 0.437) 
Mortality 0 3 (0.7%) 0.070  
Number of Episodes 1 (1-5) 2 (1-8) < 0.001  
Total Hospital Stay 6 (1-160) days 14 (2-93) days < 0.001  
Presentation to resolution 
interval 
1 (1-112) week 4 (1-72) weeks 0.009  
Note: Data in parentheses are 95% confidence intervals. TC = Transcystic, CBDE = 
Common bile duct exploration, CBD = Common Bile Duct. 
* 4 more transcystic choledochoscopies were not recorded as duct explorations. 
